Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Helius Medical Technologies Inc (NQ: HSDT )

0.1658 +0.0058 (+3.62%)
Streaming Delayed Price Updated: 3:59 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 123,194
Open 0.1600
Bid (Size) 0.1600 (3)
Ask (Size) 0.1615 (4)
Prev. Close 0.1600
Today's Range 0.1520 - 0.1670
52wk Range 0.1383 - 2.760
Shares Outstanding 28,215,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Helius to Highlight Innovative PoNS Therapy™ at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting, in Commemoration of World MS Day
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Helius Medical Technologies, Inc.
Via GlobeNewswire

Performance

YTD
-48.19%
-48.19%
1 Month
-14.45%
-14.45%
3 Month
-39.47%
-39.47%
6 Month
-47.21%
-47.21%
1 Year
-88.64%
-88.64%

More News

Read More
Helius Medical Tech: Q1 Earnings Insights
Via Benzinga
Helius Medical Technologies, Inc. Reports First Quarter 2023 Financial Results
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Earnings Outlook For Helius Medical Tech
Via Benzinga
Helius Medical Tech's Return On Capital Employed Insights
Via Benzinga
Earnings Preview For Helius Medical Tech
Via Benzinga
Helius Medical Technologies, Inc. to Release First Quarter 2023 Financial Results on May 11, 2023
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Helius Medical Technologies to Spotlight Expanded Authorizations for its PoNS Device at 2023 American Academy of Neurology Annual Meeting, Booth 1685
From Helius Medical Technologies, Inc.
Via GlobeNewswire
7 Sorry Pharma Stocks to Sell in April Before It’s Too Late
Via InvestorPlace
Looking Into Helius Medical Tech's Return On Capital Employed
Via Benzinga
Helius Medical Technologies, Inc. Announces Distribution of Series B Preferred Stock to Holders of its Class A Common Stock Intended to Facilitate a Reverse Stock Split, if Necessary
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Helius Medical Technologies and HealthTech Connex Announce Exclusive Distribution Agreement for the Portable Neuromodulation Stimulator (PoNS®) Device
From Helius Medical Technologies, Inc.; HealthTech Connex Inc.
Via GlobeNewswire
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Helius Medical Technologies Announces Authorization from Health Canada to Market Portable Neuromodulation Stimulator (PoNS®) Device for the Treatment of Gait Deficit Due to Mild and Moderate Symptoms from Stroke
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Helius Medical Technologies to Present at the 35th Annual ROTH Conference
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Helius Medical Technologies to Showcase PoNS Therapy™ at American Physical Therapy Association’s 2023 Combined Sections Meeting
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Helius Medical Technologies, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2022
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Helius Medical Technologies to Present at the Virtual Q1 Investor Summit Microcap Event, January 26, 2023
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Helius Medical Technologies, Inc. Announces Participation of Neurology Center of New England in its Therapeutic Experience Program
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Helius Extends its Patient Therapy Access Program (PTAP), Bringing the Benefits of its PoNS® Device to More People with Multiple Sclerosis
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Helius Launches UpScript Telehealth e-Commerce Site, Making it Easier for Americans with Multiple Sclerosis to Access Neurotech that can Improve their Ability to Walk
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.